First, section 340B prohibits the resale or transfer of discounted outpatient drugs to anyone other than a patient of the covered entity. [56] An individual may, be considered a patient of a covered entity if he or she satisfies a test set forth in OPA guidelines. [57] The penalty for failing to comply with the 340B antidiversion provision is forfeiture of the discounts back to the manufacturer or